127 related articles for article (PubMed ID: 16598765)
21. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.
Heath E; Tahri D; Andermarcher E; Schofield P; Fleming S; Boulter CA
BMC Dev Biol; 2008 Feb; 8():18. PubMed ID: 18289368
[TBL] [Abstract][Full Text] [Related]
22. The expression of ccn3(nov) gene in musculoskeletal tumors.
Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1.
Katsuki Y; Sakamoto K; Minamizato T; Makino H; Umezawa A; Ikeda MA; Perbal B; Amagasa T; Yamaguchi A; Katsube K
Biochem Biophys Res Commun; 2008 Apr; 368(3):808-14. PubMed ID: 18275847
[TBL] [Abstract][Full Text] [Related]
24. Domain-specific CCN3 antibodies as unique tools for structural and functional studies.
Lazar N; Manara C; Navarro S; Bleau AM; Llombart-Bosch A; Scotlandi K; Planque N; Perbal B
J Cell Commun Signal; 2007 Sep; 1(2):91-102. PubMed ID: 18481200
[TBL] [Abstract][Full Text] [Related]
25. Module-specific antibodies against human connective tissue growth factor: utility for structural and functional analysis of the factor as related to chondrocytes.
Minato M; Kubota S; Kawaki H; Nishida T; Miyauchi A; Hanagata H; Nakanishi T; Takano-Yamamoto T; Takigawa M
J Biochem; 2004 Mar; 135(3):347-54. PubMed ID: 15113833
[TBL] [Abstract][Full Text] [Related]
26. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
[TBL] [Abstract][Full Text] [Related]
27. The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling.
Perbal B; Martinerie C; Sainson R; Werner M; He B; Roizman B
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):869-74. PubMed ID: 9927660
[TBL] [Abstract][Full Text] [Related]
28. Assignment of the chicken NOV gene (alias CCN3) to chromosome 2q34-->q36: Conserved and compared synteny between avian, mouse and human.
Coullin P; Li CL; Ziercher L; Auffray C; Bernheim A; Zoorob R; Perbal B
Cytogenet Genome Res; 2002; 97(1-2):140C. PubMed ID: 12438756
[No Abstract] [Full Text] [Related]
29. CCN3 and calcium signaling.
Lombet A; Planque N; Bleau AM; Li CL; Perbal B
Cell Commun Signal; 2003 Aug; 1(1):1. PubMed ID: 14606958
[TBL] [Abstract][Full Text] [Related]
30. CCN3--a key regulator of the hematopoietic compartment.
McCallum L; Irvine AE
Blood Rev; 2009 Mar; 23(2):79-85. PubMed ID: 18752874
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
32. Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression.
Perbal B
Mol Pathol; 1999 Apr; 52(2):84-91. PubMed ID: 10474687
[TBL] [Abstract][Full Text] [Related]
33. The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated.
Su BY; Cai WQ; Zhang CG; Martinez V; Lombet A; Perbal B
Mol Pathol; 2001 Jun; 54(3):184-91. PubMed ID: 11376133
[TBL] [Abstract][Full Text] [Related]
34. CCN3 overexpression inhibits growth of callosal projections via upregulation of RAB25.
Park M; Baek IJ; Kim H; Woo DK; Park YJ; Shim S
Biochem Biophys Res Commun; 2015 Jun; 461(3):456-62. PubMed ID: 25871796
[TBL] [Abstract][Full Text] [Related]
35. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
[TBL] [Abstract][Full Text] [Related]
36. CCN proteins and cancer: two to tango.
Bleau AM; Planque N; Perbal B
Front Biosci; 2005 May; 10():998-1009. PubMed ID: 15769600
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M
Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313
[TBL] [Abstract][Full Text] [Related]
38. The thrombospondin module 1 domain of the matricellular protein CCN3 shows an atypical disulfide pattern and incomplete CWR layers.
Xu ER; Lafita A; Bateman A; Hyvönen M
Acta Crystallogr D Struct Biol; 2020 Feb; 76(Pt 2):124-134. PubMed ID: 32038043
[TBL] [Abstract][Full Text] [Related]
39. Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities.
Krupska I; Bruford EA; Chaqour B
Hum Genomics; 2015 Sep; 9():24. PubMed ID: 26395334
[TBL] [Abstract][Full Text] [Related]
40. Periostin is required for matricellular localization of CCN3 in periodontal ligament of mice.
Takayama I; Tanabe H; Nishiyama T; Ito H; Amizuka N; Li M; Katsube KI; Kii I; Kudo A
J Cell Commun Signal; 2017 Mar; 11(1):5-13. PubMed ID: 28013443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
